Categories: HealthcareNews

Cannalogue Accepts Payment by Visa Debit

New payment method for medical cannabis in Canada

TORONTO, Oct. 07, 2022 (GLOBE NEWSWIRE) — Healthcare technology company, Cannalogue adopts new payment method for legal cannabis in Canada. Starting today, Cannalogue.ca accepts payment for medical cannabis through Visa Debit. Cannalogue clients will be able to use Visa Debit to purchase medical cannabis products on Cannalogue for Canada-wide delivery. Health Canada approved medical cannabis products from Cannalogue are delivered direct-to-the-consumer from the cannabis producer assuring maximum product quality. Cannabis businesses will be able to utilize Visa Debit services for business-to-business (B2B) wholesale cannabis transactions through Cannalogue.

“We want to offer Canadians the best transaction experience and today is a big step forward for legal cannabis payments in Canada,” says President & CEO of Cannalogue, Dr. Mohan Cooray. Due to recent surcharges associated with credit cards, Visa Debit may emerge as the preferred payment method for e-commerce in Canada. Cannalogue believes Visa Debit will be beneficial to the Canadian medical cannabis consumer. “Visa Debit is particularly important for recurring essential e-commerce purchases such as medical cannabis products where the benefits of Visa Debit outweigh the risks of credit cards given the new surcharge uncertainty,” says Dr. Cooray.

To learn more about Visa Debit for medical cannabis, please visit:

www.cannalogue.ca

Media Contact:
media@cannalogue.ca

Staff

Recent Posts

The State of HTM, 2025: Report Signals Changing Health Tech Workforce

Biomedical Engineers, Clinical Engineers, Others Weigh in on State of the Health Care IndustryArlington, Virginia--(Newsfile…

23 minutes ago

Standard Process Launches Cultivate, a New Practitioner Symposium Advancing Whole-Food Nutrition and Healthy Aging

Two immersive 2026 events in Seattle and Boston will offer up to 12 CE credits,…

1 hour ago

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Total Revenue Expected to be $276 Million  MACI Revenue Expected to be $239.5 Million Fourth…

1 hour ago

Stroke Experts Challenge “90-Day Recovery” Myth: New Research Shows Patients Need Long-Term Care

Study published by Centre for Neuro Skills researchers in Brain Injury journal argues current insurance…

1 hour ago

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large,…

1 hour ago

IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as…

1 hour ago